In terms of laboratory findings, considerably higher levels of white blood cells (5.0 x 109/L [1.9–13.4] vs 4.3 x 109/L [0.8–10.4]; p = 0.008), alanine aminotransferase (26.2 U/L [11.3–93.7] vs 16.8 U/L [2.6–69.4]; p = 0.000), aspartate aminotransferase (25.7 U/L [2.0–78.8] vs 23.3 U/L [12.3–82.1]; p = 0.006), creatine kinase (85.5 U/L [11.3–986.4] vs 66.5 U/L [22.7–646.0], p = 0.002) and C reactive protein (21.3 mg/L [0.4–94.9] vs 13.1 mg/L [0.1–101.9]; p = 0.012) were detected in the patients with NAFLD than in those without NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.